HK1133876A1 - Ep2 agonists ep2 - Google Patents
Ep2 agonists ep2Info
- Publication number
- HK1133876A1 HK1133876A1 HK09110479.0A HK09110479A HK1133876A1 HK 1133876 A1 HK1133876 A1 HK 1133876A1 HK 09110479 A HK09110479 A HK 09110479A HK 1133876 A1 HK1133876 A1 HK 1133876A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- agonists
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/04—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83390706P | 2006-07-28 | 2006-07-28 | |
| US94192307P | 2007-06-04 | 2007-06-04 | |
| PCT/IB2007/002044 WO2008015517A2 (en) | 2006-07-28 | 2007-07-16 | Ep2 agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1133876A1 true HK1133876A1 (en) | 2010-04-09 |
Family
ID=38896126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK09110479.0A HK1133876A1 (en) | 2006-07-28 | 2009-11-10 | Ep2 agonists ep2 |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US7622475B2 (ja) |
| EP (1) | EP2059507B1 (ja) |
| JP (1) | JP4583500B2 (ja) |
| KR (1) | KR101088942B1 (ja) |
| AP (1) | AP2009004754A0 (ja) |
| AR (1) | AR062122A1 (ja) |
| AU (1) | AU2007280130B2 (ja) |
| BR (1) | BRPI0714683A2 (ja) |
| CA (1) | CA2659184C (ja) |
| CL (1) | CL2007002207A1 (ja) |
| CR (1) | CR10554A (ja) |
| EA (1) | EA200970067A1 (ja) |
| EC (1) | ECSP099071A (ja) |
| GT (1) | GT200700064A (ja) |
| HK (1) | HK1133876A1 (ja) |
| IL (1) | IL196355A0 (ja) |
| MA (1) | MA30604B1 (ja) |
| MX (1) | MX2009001062A (ja) |
| NO (1) | NO20090738L (ja) |
| NZ (1) | NZ573964A (ja) |
| PE (1) | PE20080408A1 (ja) |
| RS (1) | RS20090002A (ja) |
| TN (1) | TN2009000028A1 (ja) |
| TW (1) | TWI372757B (ja) |
| UY (1) | UY30511A1 (ja) |
| WO (1) | WO2008015517A2 (ja) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8648097B2 (en) * | 2008-03-12 | 2014-02-11 | Ube Industries, Ltd. | Pyridylaminoacetic acid compound |
| PL2415763T3 (pl) | 2009-03-30 | 2016-05-31 | Ube Industries | Kompozycja farmaceutyczna do leczenia lub profilaktyki jaskry |
| WO2011030873A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | ベンジル化合物 |
| WO2011030865A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | 置換ベンジル化合物 |
| WO2011030871A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | Ｎ－置換ヘテロアリール化合物 |
| AU2010293410A1 (en) * | 2009-09-11 | 2012-05-03 | Ube Industries, Ltd. | Substituted carbonyl compounds |
| KR20120068902A (ko) * | 2009-09-11 | 2012-06-27 | 우베 고산 가부시키가이샤 | 아닐린 화합물 |
| WO2011030872A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | スルホンアミド化合物 |
| CN102666490A (zh) * | 2009-12-25 | 2012-09-12 | 宇部兴产株式会社 | 氨基吡啶化合物 |
| RU2013111281A (ru) * | 2010-08-17 | 2014-09-27 | Аллерган, Инк. | Агонисты ер2 или ер4 для лечения помутнения роговицы |
| EA026702B1 (ru) | 2011-09-16 | 2017-05-31 | Санофи | Производные анилина, их получение и терапевтическое применение |
| WO2013109991A1 (en) * | 2012-01-20 | 2013-07-25 | Acucela Inc. | Substituted heterocyclic compounds for disease treatment |
| CA2867527A1 (en) | 2012-05-03 | 2013-11-07 | Takeda Gmbh | Novel ep2 receptor agonists |
| US9339496B2 (en) | 2012-07-13 | 2016-05-17 | Santen Pharmaceutical Co., Ltd. | Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonist |
| TW201527282A (zh) * | 2013-03-28 | 2015-07-16 | Ube Industries | 取代聯芳基化合物 |
| JP2017206445A (ja) * | 2014-09-26 | 2017-11-24 | 宇部興産株式会社 | 呼吸器疾患の治療及び／又は予防のための医薬組成物 |
| JP2017206443A (ja) * | 2014-09-26 | 2017-11-24 | 宇部興産株式会社 | 置換ビアリール化合物及び他の医薬の組み合わせ |
| RU2749952C2 (ru) * | 2015-07-01 | 2021-06-21 | Сантэн Фармасьютикал Ко., Лтд. | Депо-препарат, содержащий сложный эфир лимонной кислоты |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599353A (en) | 1982-05-03 | 1986-07-08 | The Trustees Of Columbia University In The City Of New York | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma |
| US5296504A (en) | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| UA59384C2 (uk) | 1996-12-20 | 2003-09-15 | Пфайзер, Інк. | Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі |
| UA67754C2 (uk) * | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
| EP1000619A3 (en) | 1998-06-23 | 2002-07-24 | Pfizer Products Inc. | Method for treating glaucoma |
| IL139941A0 (en) | 1999-12-02 | 2002-02-10 | Pfizer Prod Inc | Use of prostaglandin agonists to treat erectile dysfunction or impotence |
| US20020161026A1 (en) | 2000-11-07 | 2002-10-31 | Paralkar Vishwas M. | Combination therapies for the stimulation of bone growth |
| NZ532209A (en) | 2001-11-30 | 2007-05-31 | Pfizer Prod Inc | Controlled release microparticle pharmaceutical composition for the sustained release of an EP2 receptor selective agonist for treating bone injury or bone defect |
| CA2473984A1 (en) * | 2002-01-31 | 2003-08-07 | Pfizer Products Inc. | Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid |
| AU2004216898A1 (en) | 2003-03-04 | 2004-09-16 | Pfizer Products Inc. | Use of EP2 selective receptor agonists in medical treatment |
| US20050203086A1 (en) | 2004-03-04 | 2005-09-15 | Pfizer Inc. | Methods of treatment using an EP2 selective receptor agonist |
| US7915316B2 (en) * | 2005-08-22 | 2011-03-29 | Allergan, Inc | Sulfonamides |
| US7696235B2 (en) * | 2005-08-29 | 2010-04-13 | Allergan, Inc. | EP2 receptor agonists for treating glaucoma |
-
2007
- 2007-07-16 WO PCT/IB2007/002044 patent/WO2008015517A2/en active Application Filing
- 2007-07-16 KR KR1020097001522A patent/KR101088942B1/ko not_active IP Right Cessation
- 2007-07-16 EP EP07766635A patent/EP2059507B1/en not_active Not-in-force
- 2007-07-16 AU AU2007280130A patent/AU2007280130B2/en not_active Ceased
- 2007-07-16 CA CA2659184A patent/CA2659184C/en not_active Expired - Fee Related
- 2007-07-16 EA EA200970067A patent/EA200970067A1/ru unknown
- 2007-07-16 AP AP2009004754A patent/AP2009004754A0/xx unknown
- 2007-07-16 RS RSP-2009/0002A patent/RS20090002A/sr unknown
- 2007-07-16 BR BRPI0714683-3A patent/BRPI0714683A2/pt not_active IP Right Cessation
- 2007-07-16 NZ NZ573964A patent/NZ573964A/en not_active IP Right Cessation
- 2007-07-16 JP JP2009522350A patent/JP4583500B2/ja not_active Expired - Fee Related
- 2007-07-16 MX MX2009001062A patent/MX2009001062A/es active IP Right Grant
- 2007-07-26 PE PE2007000967A patent/PE20080408A1/es not_active Application Discontinuation
- 2007-07-26 AR ARP070103330A patent/AR062122A1/es unknown
- 2007-07-27 US US11/829,176 patent/US7622475B2/en not_active Expired - Fee Related
- 2007-07-27 GT GT200700064A patent/GT200700064A/es unknown
- 2007-07-27 UY UY30511A patent/UY30511A1/es not_active Application Discontinuation
- 2007-07-27 TW TW096127590A patent/TWI372757B/zh not_active IP Right Cessation
- 2007-07-27 CL CL200702207A patent/CL2007002207A1/es unknown
-
2009
- 2009-01-05 IL IL196355A patent/IL196355A0/en unknown
- 2009-01-13 CR CR10554A patent/CR10554A/es not_active Application Discontinuation
- 2009-01-14 EC EC2009009071A patent/ECSP099071A/es unknown
- 2009-01-26 TN TN2009000028A patent/TN2009000028A1/fr unknown
- 2009-01-28 MA MA31593A patent/MA30604B1/fr unknown
- 2009-02-16 NO NO20090738A patent/NO20090738L/no not_active Application Discontinuation
- 2009-10-07 US US12/575,373 patent/US20100105905A1/en not_active Abandoned
- 2009-11-10 HK HK09110479.0A patent/HK1133876A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI372757B (en) | Ep2 agonists | |
| HK1139137A1 (en) | Acylaminopyrazoles as fgfr inhibitors | |
| HK1176601A1 (zh) | 抑制劑 | |
| GB0709295D0 (en) | New Zealander | |
| PL1973884T3 (pl) | Nowe związki heterocykliczne | |
| HK1109502A1 (en) | Battary can | |
| EP2071010A4 (en) | GREASE | |
| IL192799A0 (en) | Substituted 4-phenylpiperidines | |
| EP2090850A4 (en) | CHILLER | |
| GB0708226D0 (en) | Y-receptor agonists | |
| EP2080799A4 (en) | GREASE | |
| ZA200900611B (en) | EP2 agonists | |
| ZA200903382B (en) | Substituted 4-imidazoles | |
| EP2222662A4 (en) | INHIBITORS OF KYNURENINE AMINO TRANSFERASE | |
| EP1973351A4 (en) | MONITOR | |
| EP2069339A4 (en) | SUBSTITUTED PIPERIDINOPHENYLOXAZOLIDINONE | |
| ZA200708752B (en) | Component | |
| EP2068747A4 (en) | DENTISTRY INSULATOR | |
| GB0714941D0 (en) | Inhibitors | |
| GB0614580D0 (en) | Agonists 1A | |
| GB0614578D0 (en) | Agonists IIA | |
| GB0516439D0 (en) | EP2 receptor agonists | |
| SI2029547T1 (sl) | Agonisti fxr farnezoid x receptorja | |
| HU0600193V0 (en) | Latch-cover for water-network | |
| GB0612494D0 (en) | Lubricant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160716 |